ITRI-227

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameITRI-227
Drug Alias Nametyrosine kinase inhibitors (ITRI)ITRI-019ITRI-020ITRI-039ITRI-068 +[9] 
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitorsAnticancer protein kinase inhibitorsStem cell growth factor receptor inhibitors
TargetsStem cell growth factor receptorTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIndustrial Technology Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIndustrial Technology Research Institute
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A